The implementation marks IBM’s first joint deployment of Watson for Oncology and Watson for Genomics in India. Watson for Oncology will go live at Apollo Hospitals’ facilities in Chennai and Bangalore in May, with other locations to follow during the coming months.
Watson for Oncology aims to help physicians identify relevant treatment options to personalize care for individual breast, lung, colorectal, gastric, cervical and ovarian cancer patients. Watson for Genomics analyzes patients’ genomic, clinical and pharmacological data to identify potential genetic alterations, drugs and clinical trials targeted toward an individual patient’s tumor.
“Each person’s cancer journey is unique and hence each patient’s treatment plan must be unique too,” Preetha Reddy, vice chairperson of the Apollo Hospitals Group, said in a May 22 statement. “IBM Watson for Oncology and Genomics will help the clinicians and oncologists at Apollo Hospitals augment their own expertise to deliver an unparalleled and personalized patient care across our hospitals.”
More articles on artificial intelligence:
Why Google renamed its research division ‘Google AI’
Mayo Clinic study uses AI to detect heart rhythm disorder
‘The mind of a mathematician with the heart of a doctor’: athenahealth CTO Prakash Khot shares 4 thoughts on AI in healthcare
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
